Concepedia

Mary F. Hébert

MF

85

Publications

7K

Citations

49

H-Index

1974

Active since

Affiliations

University of Washington(Current)

The University of Texas Medical Branch at Galveston

University of Pittsburgh

University of California, San Francisco

Indiana University – Purdue University Indianapolis

Mary F. Hébert is an author at University of Washington specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1974–2023

85

Publications

85

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

Chi-Yuan Wu, Leslie Z. Benet, Mary F. Hébert et al. · Clinical Pharmacology & Therapeutics · 1995 · 355 citations

, , +19

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

Mary F. Hébert, John P. Roberts, Thomayant Prueksaritanont et al. · Clinical Pharmacology & Therapeutics · 1992 · 338 citations

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

Mary F. Hébert · Advanced Drug Delivery Reviews · 1997 · 285 citations

, , +9

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

Denise Y. Gomez, Vincent J. Wacher, Stephen J. Tomlanovich et al. · Clinical Pharmacology & Therapeutics · 1995 · 282 citations

EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO

Yang Dai, Mary F. Hébert, Nina Isoherranen et al. · Drug Metabolism and Disposition · 2006 · 275 citations

Rows per page

1–5 of 85